Outcomes considered | Patient-oriented outcomes |
---|---|
Vitamin E has good antioxidant activity | High-dose vitamin E supplementation can lead to increased mortality |
Intensive glucose lowering can decrease HbA1c8 | Intensive glucose lowering does not decrease mortality |
Hormone replacement therapy can diminish postmenopausal osteoporosis | Hormone replacement therapy increases the risk of venous thromboembolism |
Flecainide can restore sinus rhythm in patients with ventricular tachycardia | Flecainide increases cardiac mortality for postmyocardial infarction patients |